<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(10)</volume><submitter>Lemesle G</submitter><pubmed_abstract>The relation between diabetes mellitus, glycemic control, and ischemic and bleeding events is poorly described in outpatients with stable coronary artery disease receiving modern secondary prevention. The multicenter CORONOR (Suivi d'une cohorte de patients Coronariens stables en région Nord-pas-de-Calais) registry enrolled 4184 outpatients with stable coronary artery disease, including 1297 patients (31%) with diabetes mellitus. A recent glycosylated hemoglobin (HbA1c) was available for 1146 diabetic patients, and 48% had HbA1c ≥7%. We analyzed 5-year ischemic (cardiovascular death, myocardial infarction, and stroke) and bleeding (Bleeding Academic Research Consortium ≥3) outcomes, according to diabetic status and glycemic control. When compared with nondiabetic patients, the ischemic ris</pubmed_abstract><journal>Journal of the American Heart Association</journal><pagination>e008354</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6015307</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.</pubmed_title><pmcid>PMC6015307</pmcid><pubmed_authors>Tricot O</pubmed_authors><pubmed_authors>Meurice T</pubmed_authors><pubmed_authors>Lemesle G</pubmed_authors><pubmed_authors>Lamblin N</pubmed_authors><pubmed_authors>Bauters C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.</name><description>The relation between diabetes mellitus, glycemic control, and ischemic and bleeding events is poorly described in outpatients with stable coronary artery disease receiving modern secondary prevention. The multicenter CORONOR (Suivi d'une cohorte de patients Coronariens stables en région Nord-pas-de-Calais) registry enrolled 4184 outpatients with stable coronary artery disease, including 1297 patients (31%) with diabetes mellitus. A recent glycosylated hemoglobin (HbA1c) was available for 1146 diabetic patients, and 48% had HbA1c ≥7%. We analyzed 5-year ischemic (cardiovascular death, myocardial infarction, and stroke) and bleeding (Bleeding Academic Research Consortium ≥3) outcomes, according to diabetic status and glycemic control. When compared with nondiabetic patients, the ischemic ris</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2025-04-25T19:50:56.515Z</modification><creation>2019-03-26T23:44:40Z</creation></dates><accession>S-EPMC6015307</accession><cross_references><pubmed>29728374</pubmed><doi>10.1161/JAHA.117.008354</doi></cross_references></HashMap>